Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03083964 · ClinicalTrials.gov registry record · NA
Addressing Place and People Micro Environments in Weight Loss Disparities
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 350
- Enrollment target
NCT03083964: Completed NA study, sponsored by Indiana University.
NCT03083964 is a NA study that has completed, run by Indiana University. The registered enrollment target is 350 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03083964, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
Study Summary
The purpose of this study is to A) capture obesogenic cues that occur in daily life, and B) to deliver cue alerts. Investigators hypothesized that A) black women experience more cues, B) racial disparities in obesity are reduced in models that adjust for cues, and C) the priming arm will achieve a weight loss of 2kg or more. Investigators will explore whether racial disparities in weight loss differ between the groups receiving usual care or those receiving cues.
Primary Outcome
Participants are weighed at baseline and 6 months to access if proportion is losing 2kg of body weight or more by 6 months.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Priming
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2017-01-18 |
| Est. Completion | 2021-12-11 |
| Phase | NA |
What the finished NCT03083964 record still lists
NCT03083964 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT03083964 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03083964 about?
NCT03083964 is a clinical study titled "Addressing Place and People Micro Environments in Weight Loss Disparities". The purpose of this study is to A) capture obesogenic cues that occur in daily life, and B) to deliver cue alerts. Investigators hypothesized that A) black women experience more cues, B) racial disparities in obesity are reduced in models that adjust for cues, and C) the priming arm will achieve a w...
What is the current status of trial NCT03083964?
This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2017-01-18. Estimated completion is 2021-12-11.
What interventions are being tested in trial NCT03083964?
The interventions under investigation include: Usual Care (BEHAVIORAL), Priming (BEHAVIORAL).
Who is sponsoring clinical trial NCT03083964?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03083964's enrollment target sits among peer trials
350 292nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI